How to Buy Celcuity Stock
Celcuity Inc
Celcuity Inc. , a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States.
Celcuity stock last closed at $105.25, up 4.45% from the previous day, and has increased 734.66% in one year. It has overperformed other stocks in the Biotechnology industry by 7.8 percentage points. Celcuity stock is currently +1,289.44% from its 52-week low of $7.58, and -6.56% from its 52-week high of $112.64.
There are currently 46.27M shares of CELC outstanding. The market cap of CELC is $4.87B. In the last 24 hours, 1.28M CELC shares were traded.
How to Buy Celcuity Stock
Not sure how to invest in Celcuity stock? Here's how.
- Figure out where to buy Celcuity stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Celcuity stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Pick your payment method and add your info.
- Research Celcuity stock: The Celcuity ticker symbol is CELC. Is Celcuity stock a good investment? Should you buy shares of CELC? How do CELC's underlying business fundamentals look? Do top analysts think Celcuity is a good buy? Why has CELC's stock price moved recently? (Hint: Our stock analysis website can help you figure out if CELC is a good stock to buy).
- Place your CELC purchase: Decide if you will purchase CELC shares at the current market price or use a limit order to buy CELC shares at a given price.
- Get updates on your investment in CELC: Create a watchlist to get the latest news on your position in Celcuity shares.
Step 1: Figure out where to buy Celcuity stock
You will need an online brokerage account to access the NASDAQ market and buy CELC stock.
Our favorite brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal information so you can invest in CELC today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've created your account on the stocks app, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring money into your investment account.
Step 4: Research Celcuity stock
After you have identified the best place to buy Celcuity stock, it's critical to research their stock before you buy, so you can comprehend the risk as well as the opportunity.
Celcuity quick stats
Celcuity Overview
WallStreetZen was created to help everyday investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on CELC's stock page.
Is CELC stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CELC's intrinsic value.
Using relative valuations metrics:
- CELC could be overvalued based on its P/B ratio of 41.64x, relative to Biotechnology industry P/B ratio of 5.32x
You can access more valuation research on CELC's stock here.
CELC Financials at a glance
Passed Financial Due Diligence Checks:
- CELC has $454.98M in cash and short term investments. This is sufficient to cover its annual cash burn of $144.89M.
- CELC has cash burn of 144892132. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the CELC balance sheet.
- There are more short-term assets than long-term liabilities on the CELC balance sheet.
Failed Financial Due Diligence Checks:
- Total CELC debt is higher than 5 years ago, relative to shareholder equity.
- CELC has a relatively high debt to equity ratio of 3.07.
Is it a good time to buy CELC stock, according to analysts?
Out of 8 Wall Street analysts who track CELC, the consensus analyst rating on Celcuity is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent CELC Analyst Upgrades/Downgrades
Stephen Willey, a top 22% analyst from Stifel Nicolaus maintains CELC with a strong buy rating and raises their CELC price target from $68.00 to $115.00, on Nov 13, 2025.
Stifel Nicolaus's Stephen Willey raised their price target on Celcuity (NASDAQ: CELC) by 69.1% from $68 to $115 on 2025/11/13. The analyst maintained their Strong Buy rating on the stock.
Celcuity reported its Q3 2025 earnings.
Willey attributed their price target hike to the quarter's results and takeaways from a fireside chat with CEO Brian Sullivan
Specifically, the analyst said, they updated their VIKTORIA-1 U.S. revenue and odds of success estimates.
Earnings Report
For Q3 2025, Celcuity reported:
- EPS of $(0.92), which beat the $(1.03) consensus estimate but missed Q3 2024's $(0.78).
- Revenue of $0.00, which met the $0.00 consensus estimate and Q3 2024's $0.00.
Management did not provide financial guidance in its earnings release.
CEO Brian Sullivan commented: “We made significant clinical and regulatory progress in the third quarter.
“At the ESMO Congress, we presented potentially practice-changing safety and efficacy results for the gedatolisib regimens from the PIK3CA wild-type cohort of our Phase 3 VIKTORIA-1 trial at a late-breaking oral presentation.
"We remain on track to submit the New Drug Application for gedatolisib later this year based on data from the PIK3CA wild-type cohort.
"The PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial is fully enrolled with topline data expected in late Q1 2026 or during Q2 2026.
“There is an urgent need for more efficacious therapies than those currently available for patients with HR+, HER2- advanced breast cancer who have received prior treatment with a CDK4/6 inhibitor.
"With our strengthened balance sheet and unprecedented efficacy results in this patient population, we are well-positioned to bring gedatolisib to patients should we get FDA approval.”
Gil Blum, a top 3% analyst from Needham reiterates CELC with a buy rating and maintains their CELC price target from $70.00 to $70.00, on Oct 20, 2025.
Bradley Canino, a top 20% analyst from Guggenheim initiates coverage on CELC with a strong buy rating and announces their CELC price target of $110.00, on Sep 22, 2025.
Andrew Berens, a bottom 3% analyst from Leerink Partners maintains CELC with a buy rating and raises their CELC price target from $28.00 to $60.00, on Jul 28, 2025.
You can dig deeper into what analysts are saying on the Celcuity stock forecast page.
CELC Momentum
What are CELC insiders up to?
In the past 12 months, executives and large shareholders at CELC have bought more shares than they have sold.
Richard E. Buller, Director of CELC, was the latest CELC insider to buy. They bought $16,500.00 worth of CELC shares on Dec 5, 2025.
Dig into more about who owns CELC stock here.
Can I rely on CELC as an income stream?
No, Celcuity doesn't provide an income stream by paying out dividends.
What others are saying about CELC
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your CELC purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.
Press the Open button and eToro will execute your order.
If you need additional help investing in stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in CELC
Now that you own some CELC stock, you'll want to stay up-to-date on your new investment.
Add CELC to a watchlist to keep tabs on your CELC stock.
CELC Feed
How to Buy Stock in Celcuity
To reiterate, here are the 6 steps you need to take to buy Celcuity stock right now:
- Figure out where to buy Celcuity stock
- Sign up for your brokerage account
- Fund your brokerage account
- Research Celcuity stock
- Place your CELC purchase
- Get updates on your investment in CELC
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Celcuity, get started below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.